<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
  <head>
<meta http-equiv="content-type" content="text/html; charset=utf-8">
    <title>FURM - Hepatic Intrinsic Clearance</title>
    <style>
             dt {
               font-weight: bold;
             }
             main {
               text-align: left;
             }
             dd {
               line-height: 200%;
             }
             td {
               text-align: left;
             }
             p {
                text-align: left;
               }
          </style>
<script language="JavaScript">
<!--
function na_open_window(name, url, left, top, width, height, toolbar, menubar, statusbar, scrollbar, resizable)
{
  toolbar_str = toolbar ? 'yes' : 'no';
  menubar_str = menubar ? 'yes' : 'no';
  statusbar_str = statusbar ? 'yes' : 'no';
  scrollbar_str = scrollbar ? 'yes' : 'no';
  resizable_str = resizable ? 'yes' : 'no';
  window.open(url, name, 'left='+left+',top='+top+',width='+width+',height='+height+',toolbar='+toolbar_str+',menubar='+menubar_str+',status='+statusbar_str+',scrollbars='+scrollbar_str+',resizable='+resizable_str);
}

// -->
</script>
  </head>

  <body bgcolor="#3366cc" text="#ffffcc" link="#99ccff" alink="#cc00cc" vlink="#cc0066">
   <iframe src="..\menu.html" frameborder="0" width="100%"></iframe>


   <center><h1>IS-HIC: In Silico Hepatic Intrinsic Clearance</h1></center>

<div align="left">
    <table border="0" width="624">
        <tr>
            <td width="104" height="779" valign="top">
                <p><a href="../is-hic.html"><img src="../img/ishic/abstract.gif" width="88" height="32" border="0"></a></p>
                <p><a href="methods.htm"><img src="../img/ishic/methods.gif" width="88" height="32" border="0"></a></p>
                <p><a href="results.htm"><img src="../img/ishic/results.gif" width="88" height="32" border="0"></a></p>
                <p><a href="download.htm"><img src="../img/ishic/download.gif" width="88" height="32" border="0"></a></p>
            </td>
            <td width="510" height="164" valign="top">                    <p class="MsoNormal" align="left"><font size="5"><b>&nbsp;<a name="Methods"></a></b></font><font size="6"><b>Methods</b></font>
                <ul>
                    <div align="left">
                        <li class="MsoNormal"><a href="#ArtModel"><font size="4">ArtMode</font></a><font size="4"><a href="#ArtModel">l</a></font></li>
                        <li class="MsoNormal"><a href="#RefModel"><font size="4">RefModel</font></a></li>
                        <li class="MsoNormal"><a href="#DatModel"><font size="4">DataModel</font></a></li>
                        <li class="MsoNormal"><a href="#SM"><font size="4">Similarity 
                        Measure</font></a></li>
                        <li class="MsoNormal"><a href="#OPT"><font size="4">Model 
                        Optimization</font></a></li>
                        <li class="MsoNormal"><font size="4"><a href="#REFERENCES">References</a></font></li>
                    </div>
                </ul>
<TABLE cellSpacing=10 width="100%" border=0>
<TBODY>
<TR>
<TD width="488">
<P class=MsoNormal 
style="TEXT-ALIGN: justify; mso-layout-grid-align: none"><b><font size="4"><a name="ArtModel"></a></font><font size="5">ArtModel</font></b></P>
<P style="TEXT-ALIGN: justify; mso-layout-grid-align: none"><span style="mso-bidi-font-size: 12.0pt"><font size="3">The IS-HIC ArtModel consists of 
three basic components, <I style="mso-bidi-font-style: normal">solute objects, 
hepatocytes</I> and a <I style="mso-bidi-font-style: normal">WanderSpace</I>. <I 
style="mso-bidi-font-style: normal"><SPAN 
style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp;</SPAN></I>The solute 
objects and hepatocyte agents are the exact same as the corresponding components 
used in the ISL <a href="#REFERENCES">[9]</a>.</font></span></P>
<P align=center><a target="_self"><a name="fig1"></a></a><a href="javascript:na_open_window('ISHIC_FIG1', '../img/ishic/ishic-fig1.GIF', 0, 0, 557, 320, 0, 0, 0, 0, 1)" target="_self"><img src="../img/ishic/ishic-fig1-sml.gif" width="300" height="161" border="0" alt="Click to enlarge"></a>
                            <p align="center">(a) A single hepatocyte</p>
                            <p align="center"><img src="../img/ishic/space.gif" width="300" height="225" border="0"></p>
                            <p align="center">(b) Hepatocytes and solute objects 
                            in the 2D space</p>

                            <p align="center">Fig1</p>
                            <p align="left" style="text-indent:25;"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt"><B 
style="mso-bidi-font-weight: normal"><I 
style="mso-bidi-font-style: normal">Solute objects</I></B>: solute objects are 
the mobile objects representing a group of molecules of the chemical compound 
(the test drug) as they move around in the reaction mixture. These in silico 
objects can be parameterized to make their behavior similar to that of a drug<I 
style="mso-bidi-font-style: normal"> in vitro</I>.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>The more relevant 
parameters are as follows.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span>SoluteBindingProb: The probability that a specific type of drug object 
will bind to a Binder within a hepatocyte.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span>SoluteBindingCycles: The number of steps that a drug object remain 
attached to a Binder; embraneCrossing: indicates whether a compound can or 
cannot enter hepatocytes.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>A solute object 
is destroyed once it is “metabolized.”<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>Metabolites are 
not currently tracked.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span></span></font></p>
<P 
style="TEXT-INDENT: 18.7pt; TEXT-ALIGN: justify; mso-layout-grid-align: none" align="left"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt"><B 
style="mso-bidi-font-weight: normal"><I 
style="mso-bidi-font-style: normal">Binder:</I></B> Objects within hepatocyte 
agents that can both bind and metabolize compounds.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>Each Binder 
represents a fraction of all subcellular components that can bind or sequester a 
drug object, and includes a fraction of all metabolizing enzymes.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span></span></font></P>
<P 
style="TEXT-INDENT: 18.7pt; TEXT-ALIGN: justify; mso-layout-grid-align: none" align="left"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt"><B 
style="mso-bidi-font-weight: normal"><I 
style="mso-bidi-font-style: normal">Hepatocytes</I>:</B> These objects are the 
agents representing the isolated hepatocytes suspended in the <I 
style="mso-bidi-font-style: normal">in vitro</I> cell culture media.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>They are capable 
of taking in, binding and metabolizing drug objects.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>The parameters 
are: BindersPerCellMin, BindersPerCellMax: Minimum and maximum binders per cell, 
respectively.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span>MetabolizationProb: The probability that the cell metabolizes an attached 
solute object at the end of its binding period. </span></font></P>
<P style="TEXT-INDENT: 18.7pt; TEXT-ALIGN: justify" align="left"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt"><B 
style="mso-bidi-font-weight: normal"><I 
style="mso-bidi-font-style: normal">WanderSpace</I></B> is a fine-grained space, 
representing the <I 
style="mso-bidi-font-style: normal">in vitro</I> cell 
culture, in which solute objects and hepatocytes interact with each other.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>SpaceWidth, 
SpaceLength: Width and length of WanderSpace.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>HepDensity: The 
density of hepatocytes in the space.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>TotalSoluteMass: 
The total compound mass initially added to WanderSpace.</span></font></P>
<P style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify" align="left"><span style="mso-bidi-font-size: 12.0pt"><font size="3">Functioning of the IS-HIC 
ArtModel: First, hepatocyte agents are placed randomly in the WanderSpace as 
fixed objects.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span>Drug (and other) mobile objects are then randomly placed within the space 
(external to all hepatocytes) based on an initial concentration (see <a href="#fig1">Figure 
1</a>).<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; </span>The 
mobile objects move randomly, while the hepatocytes have the opportunity to 
“take up” and then metabolize nearby solute objects.<span style="mso-spacerun: yes; mso-bidi-font-size: 12.0pt">&nbsp; 
</span></font></span></P>
                            <p style="text-align:justify; text-indent:0.25in;" align="center"><SPAN 
style="FONT-SIZE: 10pt; mso-bidi-font-size: 12.0pt"><a name="fig2"></a></SPAN><a href="javascript:na_open_window('ISHIC_Fig2', '../img/ishic/ishic-fig2.GIF', 0, 0, 400, 438, 0, 0, 0, 0, 1)" target="_self"><img src="../img/ishic/ishic-fig2-sml.gif" width="250" height="265" border="0" alt="Click to enlarge"></a></p>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; WORD-SPACING: 0px" 
align=center>Fig 2</P></TD>
</TR></TBODY></TABLE>
<P align=left>&nbsp;<a href="#Methods">Back to Top</a> 
<DIV align=center>
<CENTER>
<TABLE cellSpacing=20 width="100%" border=0>
<TBODY>
<TR>
<TD vAlign=top width="50%">
<H2><span style="mso-bidi-font-size: 14.0pt"><font size="4"><a name="RefModel"></a></font><font size="5">RefModel</font></span></H2>
<P class=MsoNormal style="TEXT-INDENT: 0.25in" align=center><span style="mso-bidi-font-size: 12.0pt"><font size="3"><span style="mso-spacerun: yes">&nbsp;</span>The metabolic rate decreases in proportion to 
the local drug concentration as given by equation (1), where <I style="mso-bidi-font-style: normal">k</I> is a first order rate constant <a href="#REFERENCES">[12]</a> 
</font></span></P>
<P class=MsoNormal style="TEXT-INDENT: 0.25in" align=center><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dC/dt=-kC(t)</span><SPAN 
style="FONT-WEIGHT: normal; mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
</SPAN></FONT><SPAN style="FONT-WEIGHT: normal"><FONT size=3>(<SPAN style="mso-field-code: '" ARABIC&quot;? \\* \( 
SEQ>1</SPAN></FONT></SPAN><FONT size=3><SPAN 
style="FONT-WEIGHT: normal">)</SPAN></FONT></P>
<P class=MsoNormal style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify"><span style="mso-bidi-font-size: 12.0pt"><font size="3">Intrinsic clearance is a measure 
of enzyme activity, and is independent of physiological factors such as the 
liver blood flow or drug binding in the blood. In vitro, the intrinsic clearance 
of a drug is commonly expressed by equation 2, where <I style="mso-bidi-font-style: normal">C<SUB>s</SUB></I> is the concentration of 
the unbound drug at the enzyme site <a href="#REFERENCES">[12]</a>.</font></span></P>
<P class=MsoCaption 
style="MARGIN: 4pt 0in; tab-stops: center 121.55pt left 215.05pt 4.0in"><FONT 
size=3><SPAN style="FONT-WEIGHT: normal"><I 
style="mso-bidi-font-style: normal">Rate of metabolism:<SPAN 
style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>V = CL<SUB>int</SUB> C<SUB>s<SPAN 
style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SPAN></SUB></I><SPAN 
style="mso-tab-count: 1"><SUB><I 
style="FONT-WEIGHT: normal; mso-bidi-font-style: normal; mso-tab-count: 1">&nbsp;</I></SUB><I 
style="FONT-WEIGHT: normal; mso-bidi-font-style: normal; mso-tab-count: 1"><SUB> 
</SUB></I><SUB><I style="mso-bidi-font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
</I></SUB></SPAN></SPAN><SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">(</SPAN> <SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">2</SPAN> <SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">)</SPAN><SPAN 
style="FONT-WEIGHT: normal"> 
</SPAN></FONT></P>
<P class=MsoNormal 
style="TEXT-INDENT: 9pt; TEXT-ALIGN: justify; tab-stops: 99.0pt 4.0in"><span style="mso-bidi-font-size: 12.0pt"><font size="3">Rate of metabolism is generally 
defined by the Michaelis-Mention enzyme kinetics relationship. When the drug 
concentration is much smaller than <I style="mso-bidi-font-style: normal">K<SUB>m</SUB></I> (the Michaelis-Mention 
constant), CL<sub>int </sub><span style="mso-spacerun: yes">&nbsp;</span>becomes:</font></span></P>
<P class=MsoCaption 
style="MARGIN: 4pt 0in; tab-stops: center 121.55pt left 215.05pt 4.0in"><SPAN 
style="FONT-WEIGHT: normal"><SPAN style="mso-tab-count: 1"><FONT size=3><I 
style="mso-bidi-font-style: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I><I 
style="FONT-WEIGHT: normal; mso-bidi-font-style: normal; mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
</I><I 
style="mso-bidi-font-style: normal">&nbsp;&nbsp;&nbsp; </I></FONT></SPAN><I 
style="mso-bidi-font-style: normal"><FONT size=3>CL<SUB>int </SUB>= 
V/C<SUB>s</SUB></FONT></I></SPAN><FONT size=3><SPAN 
style="FONT-WEIGHT: normal; mso-tab-count: 1"><SUB>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; 
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SUB></SPAN><SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">(</SPAN> 
<SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">3</SPAN> <SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">)</SPAN><SPAN 
style="FONT-WEIGHT: normal"> </SPAN></FONT></P>
<P class=MsoNormal 
style="TEXT-INDENT: 9pt; TEXT-ALIGN: justify; tab-stops: 99.0pt 4.0in"><span style="mso-bidi-font-size: 12.0pt"><font size="3">What we need for our 
mathematical reference model, is an equation that describes the concentration of 
the unchanged drug as a function of time. Researchers use the following equation 
to express the concentration of unchanged drug for in vitro experiments, when 
keeping the initial drug concentration much smaller than <I style="mso-bidi-font-style: normal">K<SUB>m</SUB></I>:</font></span></P>
<P class=MsoNormal 
style="TEXT-INDENT: 9pt; TEXT-ALIGN: justify; tab-stops: 99.0pt 4.0in"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
dC/dt=-CL*D*C(t)</span></font><SPAN style="mso-tab-count: 1"><FONT 
size=3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></SPAN><FONT size=3><SPAN 
style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><SPAN 
style="FONT-WEIGHT: normal">(<SPAN 
style="FONT-WEIGHT: normal"> </SPAN><SPAN style="mso-field-code: '" 
ARABIC&quot;? \\* \( SEQ>4 </SPAN>) </SPAN></FONT></P>
<P class=MsoBodyTextIndent><FONT 
size=3>where C(t) is the concentration, CL the 
in vitro clearance of the drug and D the cell density.</FONT></P>
<P class=MsoNormal 
style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify; mso-layout-grid-align: none"><span style="mso-bidi-font-size: 12.0pt"><font size="3">By solving differential equation 
(4) the amount of drug remaining after incubation time T is expressed as 
follows:</font></span></P>
<P class=MsoNormal 
style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify; mso-layout-grid-align: none"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
C(T)=C(0)*exp(-CL*D*T)</span></font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; <FONT 
size=3><SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">(</SPAN> <SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">5</SPAN> <SPAN class=CaptionChar 
style="FONT-WEIGHT: normal">)</SPAN><SPAN 
style="FONT-WEIGHT: normal"> 
</SPAN></FONT></P>
<P class=MsoNormal 
style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify; mso-layout-grid-align: none"><span style="mso-bidi-font-size: 12.0pt"><font size="3">The basic equations explained 
above cannot be applied to all drugs, but they are applicable to the drugs and 
conditions selected for this study, and so we use equation 5 to express <I style="mso-bidi-font-style: normal">in vitro</I> clearance and to be the 
reference model for IS-HIC.</font></span></P><P align=left><a href="methods.htm#Methods">Back 
                                    to Top</a><H2><span style="mso-bidi-font-size: 14.0pt"><font size="4"><a name="DatModel"></a></font><font size="5">DatModel</font></span></H2>
<P class=MsoNormal style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify"><span style="mso-bidi-font-size: 12.0pt"><font size="3">The DatModel represents the real 
biological system. It contains the data obtained from <I style="mso-bidi-font-style: normal">in vitro</I> experiments, and is used to 
validate the in silico model (<a href="#ArtModel">ArtModel</a>).<span style="mso-spacerun: yes">&nbsp; 
</span>The validation process involves measuring the output of the in silico 
model and comparing it with the data provided by DatModel. In this work the data 
was obtained from Fig.<span style="mso-spacerun: yes">&nbsp; </span>2 of <a href="#REFERENCES">[11]</a>, which 
depicts the time course for nine unchanged compounds in cell culture media 
containing freshly isolated rat hepatocytes different compounds. The data points 
were carefully obtained from the graphs using computer design tools. The 
DatModel interpolates the data points using a linear interpolation method to 
estimate the drug concentration at each time step of the simulation.<span style="mso-spacerun: yes">&nbsp; </span></font></span></P>
<P align=left><a href="methods.htm#Methods">Back to Top</a><H2><span style="mso-bidi-font-size: 14.0pt"><font size="4"><a name="SM"></a></font><font size="5">The Similarity 
Measure</font></span></H2>
<P class=MsoNormal 
style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify; mso-layout-grid-align: none"><SPAN style="mso-bidi-font-size: 12.0pt">After each in silico experiment 
a <I style="mso-bidi-font-style: normal">similarity measure</I> algorithm 
compares the output of that experiment with the data provided by DatModel and 
assigns a score to the output based on the degree of their similarity. Several 
similarity measure algorithms are surveyed in <a href="#REFERENCES">[13]</a>. The similarity measure used 
in this work was the measure calculated by the “global standard deviation” 
method <a href="#REFERENCES">[13],</a>&nbsp; with a wider envelope: <SPAN 
style="mso-tab-count: 1">&nbsp;</SPAN><BR><I style="mso-bidi-font-style: normal">upper<SUB>i </SUB>= 
m<SUB>i</SUB></I></SPAN><I style="mso-bidi-font-style: normal"><SPAN 
style="FONT-FAMILY: Symbol; mso-bidi-font-size: 12.0pt; mso-char-type: symbol; mso-symbol-font-family: Symbol; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman"> 
</SPAN><SPAN style="mso-bidi-font-size: 12.0pt">(1 + sd) + 10, lower<SUB>i 
</SUB>= m<SUB>i</SUB> (1 – sd) – 10, </SPAN></I><SPAN style="mso-bidi-font-size: 12.0pt">where <I style="mso-bidi-font-style: normal">m<SUB>i</SUB> </I>and <I style="mso-bidi-font-style: normal">sd</I> are the nominal mean and standard 
deviation of the time series (for additional detail see <a href="#REFERENCES">[13]</a>).<span style="mso-spacerun: yes">&nbsp; </span>This score is calculated by counting the 
number<span style="mso-spacerun: yes">&nbsp; </span>of observations of the candidate 
time series that fall within the envelope and dividing that by the total 
observations in the series <a href="#REFERENCES">[13]</a>, as a result <i><span style="mso-text-raise: -7.0pt">similatiry_score</span></i> is 
                                    in  
</SPAN><I style="mso-bidi-font-style: normal"><SPAN style="mso-bidi-font-size: 12.0pt">[0,1]. </SPAN></I></P>
<P align=left><a href="methods.htm#Methods">Back to Top</a><P>&nbsp;<a name="OPT"></a><font size="5"><b>MODEL OPTIMIZATION</b></font></P><P style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify">By model optimization we mean finding a set of model parameter values for 
ArtModel which produce the maximum possible similarity score. Several simulation 
optimization methods are surveyed in <a href="#REFERENCES">[17]</a>, including the Nelder and Mean simplex 
search method.</P>
<P style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify">The Nelder and Mead algorithm, introduced in <a href="#REFERENCES">[18]</a> for the first time, has 
been used widely to solve parameter estimation problems for almost 40 years. 
Despite its age it is still the method of choice for many practitioners in the 
fields of statistics, engineering and the physical and medical sciences because 
it is straightforward to code and easy to use. Particularly, it’s been used 
widely by researchers for simulation optimization <a href="#REFERENCES">[18-22]</a>. It belongs to a class 
of methods which do not require derivatives and which are often claimed to be 
robust for problems with discontinuities or where function values are noisy. 
This property makes it a good candidate for optimizing our stochastic in silico 
simulation.</P>
<P style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify">There are several different versions and extensions of this optimization 
algorithm. <SPAN style="mso-bidi-font-size: 12.0pt">We used the one described in 
                                    <a href="#REFERENCES">[16]</a> to optimize our parameters.</SPAN></P>
<P style="TEXT-INDENT: 0.25in; TEXT-ALIGN: justify"><SPAN style="mso-bidi-font-size: 12.0pt"><a href="#fig3">Figure 3</a> shows the simplex 
algorithm employed in this paper. </SPAN><SPAN 
style="FONT-FAMILY: Symbol; mso-bidi-font-size: 12.0pt; mso-char-type: symbol; mso-symbol-font-family: Symbol; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">q</SPAN><SPAN style="mso-bidi-font-size: 12.0pt">&shy;<sub>best</sub>,</SPAN><SPAN 
style="FONT-FAMILY: Symbol; mso-bidi-font-size: 12.0pt; mso-char-type: symbol; mso-symbol-font-family: Symbol; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">q</SPAN><sub><span style="mso-bidi-font-size: 12.0pt">worst</span></sub><SPAN style="mso-bidi-font-size: 12.0pt"> and </SPAN><SPAN 
style="FONT-FAMILY: Symbol; mso-bidi-font-size: 12.0pt; mso-char-type: symbol; mso-symbol-font-family: Symbol; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">q</SPAN><sub><span style="mso-bidi-font-size: 12.0pt">&shy;next-worst</span></sub><SPAN style="mso-bidi-font-size: 12.0pt"> are the best, worst and next worst vertex of 
the simplex. There are four basic operations used in this algorithm: reflect, 
contract,<span style="mso-spacerun: yes">&nbsp; </span>expand and shrink each of 
which is depicted for a 2D simplex in <a href="#fig4">Figure 4</a>. The general heuristic in this 
search method is to move away from the worst point toward the 
best.</SPAN></P>
                                    <p class="MsoNormal" style="text-align:justify; text-indent:0.25in;" align="center"><FONT 
size=3><SPAN style="mso-bidi-font-size: 12.0pt"><a target="_self"><a name="fig3"></a></a><a href="javascript:na_open_window('ISHIC_Fig3', '../img/ishic/ishic-fig3.gif', 0, 0, 730, 700, 0, 0, 0, 1, 1)" target="_self"><img src="../img/ishic/ishic-fig3-sml.gif" width="350" height="333" border="0" alt="Click to enlarge"></a></span></font></p>
                                    <p class="MsoNormal" style="text-align:justify; text-indent:0.25in;" align="center">Fig 
                                    3</p>
                                    <p class="MsoNormal" style="text-align:justify; text-indent:0.25in;" align="center"><a name="fig4"></a><img src="../img/ishic/ishic-fig4-sml.gif" width="400" height="162" border="0" alt="Click to enlarge"></p>
                                    <p class="MsoNormal" style="text-align:justify; text-indent:0.25in;" align="center">Fig 
                                    4</p>
<P align=left><a href="methods.htm#Methods">Back to Top</a>

<h1 style='margin-left:0in;text-indent:0in;mso-list:none;tab-stops:.5in'><font size="4"><a name="REFERENCES"></a></font><font size="5">REFERENCES</font></h1>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[1]
Hunt, C.A., G.E.P. Ropella, M.S. Roberts,
and L. Yan, 2004, “Biomimetic In Silico Devices. Computational Methods in
Systems Biology,” Second International Workshop, CMSB 2004 (Paris, France,
May 26-28, 2004) Proceedings.<span style='mso-spacerun:yes'>&nbsp; </span>Lecture
Notes in Bioinformatics, Springer (in press); available at
                                    <a href="http://biosystems.ucsf.edu/Researc/RecentPapers/HuntCMSB04b.pdf">http://biosystems.ucsf.edu/Researc/RecentPapers/HuntCMSB04b.pdf</a>.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[2]
Leahy, D.E., 2004, “Drug Discovery Information Integration: Virtual Humans for
Pharmacokinetics,” DDT: Biosilico. 2, no. 2: 78-84.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[3]
Lipscomb, J.C., M. Meek, K. Krishnan, G.L. Kedderis, H. Clewell, and L. Haber,
2004, “Incorporation of Pharmacokinetic and Pharmacodynamic Data Into Risk
Assessments,” Toxicology Mechanisms and Methods, 14, no. 3: 145-158.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[4]
Gunaratna, C., 2001, “Drug Metabolism and Pharmacokinetics in Drug Discovery: A
Primer for Bioanalytical Chemists, Part II,” Current Separations, 19, no. 3
(www.currentseparations.com/issues/19-3/19-3e.pdf. </span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[5]
Venkatakrishnan, K., L.L. von Moltke, and D.J. Greenblatt, 2001, “Human Drug
Metabolism and the Cytochromes P450: Application and Relevance of In Vitro
Models,” Journal of Clinical Pharmacology, 41, no. 11: 1149-1179.</span></p>

<p class=MsoNormal style='text-align:justify;mso-layout-grid-align:none;
text-autospace:none'><span style='font-size:9.0pt'>[6] Takahashi, K., K. Kaizu,
B. Hu, and M. Tomita, 2004, “A Multi-algorithm, Multi-timescale Method for Cell
Simulation,” Bioinformatics, 20, no. 4: 538-46. </span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[7]
Meng,T.C., S. Somani, and P. Dhar, 2004,
“Modeling and Simulation of Biological Systems with Stochasticity,” In Silico
Biology, 4, 0024.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[8]
S. Eklins, 2003, “In Silico Approaches to Predicting Drug Metabolism,
Toxicology and Beyond,” Biochemical Society Transactions, 31,(Pt 3): 611-4.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[9]
Ropella, G.E.P., and C.A. Hunt, 2003, “Prerequisites for Effective
Experimentation in Computational Biology,” 25th Annual Conference of the IEEE
Engineering in Medicine and Biology Society (Cancun,
September 17-21, 2003); available at
                                    <a href="http://128.218.188.153:8080/~gepr/furm/docs/EMBC03Paper1.pdf">http://128.218.188.153:8080/~gepr/furm/docs/EMBC03Paper1.pdf</a>.</span></p>

<p class=MsoNormal style='text-align:justify;mso-layout-grid-align:none;
text-autospace:none'><span style='font-size:9.0pt'>[10] </span><span
class=firstname><span lang=EN style='font-size:9.0pt;mso-ansi-language:EN'>Daniels</span></span><span
class=surname><span lang=EN style='font-size:9.0pt;mso-ansi-language:EN'>, </span></span><span
class=firstname><span lang=EN style='font-size:9.0pt;mso-ansi-language:EN'>M.,
1999, </span></span><span class=surname><span lang=EN style='font-size:9.0pt;
mso-ansi-language:EN'>“</span></span><span lang=EN style='font-size:9.0pt;
mso-ansi-language:EN'>Integrating Simulation Technologies with Swarm,” Agent
Simulation: Applications, Models and Tools Conference (University of Chicago,
October 1999); available at <a href="http://www.santafe.edu/~mgd/anl/anlchicago.html">http://www.santafe.edu/~mgd/anl/anlchicago.html</a> 
                                    .<a
style='mso-footnote-id:ftn1' href="#_ftn1" name="_ftnref1" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'><span
class=MsoFootnoteReference><span lang=EN style='font-size:9.0pt;font-family:
"Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language:
EN;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>[1]</span></span></span></span></a></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[11]
Naritomi,Y., S. Terashita, A. Kagayama, and Y.
Sugiyama, 2003, “Utility of Hepatocytes in Predicting Drug Metabolism:
Comparison of Hepatic Intrinsic Clearance in Rats and Humans In Vivo and In
Vitro,” Drug Metabolism and Disposition, 31, no. 5: 580-588.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[12]
Shibata, Y., H. Takahashi, and Y. Ishii, 2000, “A Convenient In Vitro Screening
Method for Predicting In Vivo Drug Metabolic Clearance Using Isolated
Hepatocytes Suspended in Serum,” Drug Metabolism and Disposition, 28, no. 12:
1518-1523.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[13]
Ropella, G.E.P., D.A. Nag, and C.A. Hunt, 2000, “Similarity Measures for
Automated Comparison of In Silico and In Vitro Experimental Results,” ibid;
available at <a href="http://128.218.188.153:8080/~gepr/furm/docs/EMBC03Paper2.pdf">http://128.218.188.153:8080/~gepr/furm/docs/EMBC03Paper2.pdf</a> 
                                    .</span></p>

<p class=MsoNormal style='text-align:justify;mso-layout-grid-align:none;
text-autospace:none'><span style='font-size:9.0pt'>[14] Treijtel, N., A.
Barendregt, A.P. Freidig, B.J. Blaauboer, and J.C.H. van Eijkeren, 2004,
“Modeling the In Vitro Intrinsic Clearance of the Slowly Metabolized Compound
Tolbutamide Determined in Sandwich-Cultured Rat Hepatocytes,” Drug Metabolism
and Disposition, 32, no. 8: 884-891.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[15]
Haenen, B., C. Rompelberg, K. Van Twillert, M. Hamzink, J. Dormans, and J. Van
Eijkeren, 2002, “Utility of Rat Liver Slices to Estimate Hepatic Clearance for
Application in Physiologically Based Pharmacokinetic Modeling: A Study With
Tolbutamide, a Compound with Low Extraction Efficiency,” Drug Metabolism and
Disposition, 30, no. 3: 307-313.</span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:9.0pt'>[16]
H.G. Neddermeijer &amp; G.J. van Oortmarssen &amp; N. Piersma &amp; R. Dekker,
2000, &quot;Adaptive extensions of the Nelder and Mead Simplex Method for
optimization of stochastic simulation models,&quot; Econometric Institute
Report 199, Erasmus University Rotterdam, Econometric Institute.</span></p>

                                    <p class="MsoNormal" style="text-align:justify;"><a href="#Methods">Back 
                                    to Top</a></p>
<div style='mso-element:footnote-list'><div style='mso-element:footnote' id=ftn1>

<p class=MsoFootnoteText style='line-height:9.0pt;mso-line-height-rule:exactly'>&nbsp;</p>

</div>

</div>

</TD></TR></TBODY></TABLE></CENTER></DIV></td>
        </tr>
    </table>
</div>
   <p align="left">

<br><br><br>

   <iframe src="../menu.html" frameborder="0" width="100%"></iframe>
   <iframe src="../footer.html" frameborder="0" width="100%"></iframe>

<!-- Created: Wed Jan 14 17:41:27 PST 2004 -->
<!-- hhmts start -->
Last modified: Fri Feb 25 11:09:44 PST 2005
<!-- hhmts end -->
  </body>
</html>
